Prognostic Value of Mean Platelet Volume-To-Monocyte Ratio and Ferritin in NSTEMI: Independent Impact of Angiotensin-Converting Enzyme Inhibitor Therapy
Elevated admission MMR and ferritin were independently associated with a higher 1-year risk of MACE in patients with NSTEMI. ACE inhibitor therapy was associated with improved outcomes, although causality cannot be inferred. These findings suggest that readily available inflammatory biomarkers may complement established clinical parameters for early risk stratification and support continued guideline-directed pharmacotherapy in NSTEMI.
Authors
- Amir Bećirović (ORCID: https://orcid.org/0000-0002-7012-8064)
- Emir Begagić (ORCID: https://orcid.org/0000-0002-3988-8911)
- Kenana Ljuca (ORCID: https://orcid.org/0009-0004-9478-3284)
- Emir Bečirović (ORCID: https://orcid.org/0000-0002-4134-987X)
- Minela Bećirović (ORCID: https://orcid.org/0009-0007-4391-5226)
- Nadina Ljuca (ORCID: https://orcid.org/0009-0008-0832-3644)
- Admir Abdić
- Salih Hammami
Institutions
- University of Tuzla (BA)
- University of Zenica (BA)
- Ljubljana University Medical Centre (SI)
- University Clinical Center Tuzla (BA)
- University of Bihać (BA)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1177/10600280261422203
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00